JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$2.04B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.31B |
| 3 |
Apple
AAPL
|
+$746M |
| 4 |
Trane Technologies
TT
|
+$676M |
| 5 |
AABA
Altaba Inc
AABA
|
+$658M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.16B |
| 2 |
Honeywell
HON
|
+$701M |
| 3 |
iShares Russell Mid-Cap ETF
IWR
|
+$667M |
| 4 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$656M |
| 5 |
General Motors
GM
|
+$586M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.9% |
| 2 | Financials | 14.86% |
| 3 | Technology | 11.73% |
| 4 | Healthcare | 9.66% |
| 5 | Consumer Discretionary | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
MORE
2276
DELISTED
Monogram Residential Trust, Inc.
MORE
| $5.58M | ﹤0.01% |
574,242
-93,982
| -14% | -$934K |
2015 Q4
6 quarters
|
|
2277
Silicon Laboratories
SLAB
$7.43B
| $5.56M | ﹤0.01% |
81,374
-32,659
| -29% | -$2.36M |
2015 Q4
6 quarters
|
|
2278
Southside Bancshares
SBSI
$908M
| $5.56M | ﹤0.01% |
159,164
-10,908
| -6% | -$366K |
2014 Q4
10 quarters
|
|
|
BLD
2279
DELISTED
TopBuild
BLD
| $5.56M | ﹤0.01% |
104,730
-53,860
| -34% | -$2.76M |
2015 Q3
7 quarters
|
|
2280
SouthState Bank Corp
SSB
$9.85B
| $5.54M | ﹤0.01% |
64,709
-4,633
| -7% | -$400K |
2014 Q3
11 quarters
|
|
|
ZYNE
2281
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $5.54M | ﹤0.01% |
326,450
+325,950
| +65,190% | +$6.48M |
2017 Q1
1 quarter
|
|
2282
Coca-Cola Europacific Partners
CCEP
$44.9B
| $5.53M | ﹤0.01% |
147,149
+128,215
| +677% | +$5.08M |
2013 Q2
16 quarters
|
|
|
CIVI
2283
DELISTED
Civitas Solutions, Inc.
CIVI
| $5.5M | ﹤0.01% |
314,550
-9,250
| -3% | -$160K |
2015 Q4
6 quarters
|
|
|
FCE.A
2284
DELISTED
Forest City Realty Trust, Inc.
FCE.A
| $5.5M | ﹤0.01% |
227,589
+223,248
| +5,143% | +$5.15M |
2013 Q2
16 quarters
|
|
2285
Radian Group
RDN
$4.52B
| $5.5M | ﹤0.01% |
336,132
+180,109
| +115% | +$3.08M |
2016 Q4
2 quarters
|
|
2286
Hecla Mining
HL
$11.5B
| $5.48M | ﹤0.01% |
1,073,878
+1,033,961
| +2,590% | +$5.73M |
2015 Q4
6 quarters
|
|
|
CS
2287
DELISTED
Credit Suisse Group
CS
| $5.47M | ﹤0.01% |
375,036
+200,715
| +115% | +$2.9M |
2013 Q2
16 quarters
|
|
2288
Phibro Animal Health
PAHC
$1.51B
| $5.47M | ﹤0.01% |
147,602
+16,218
| +12% | +$529K |
2014 Q2
12 quarters
|
|
2289
Prothena Corp
PRTA
$414M
| $5.46M | ﹤0.01% |
100,975
+10,822
| +12% | +$577K |
2014 Q4
10 quarters
|
|
|
RDUS
2290
DELISTED
Radius Health, Inc.
RDUS
| $5.45M | ﹤0.01% |
120,554
-58,780
| -33% | -$2.25M |
2014 Q2
12 quarters
|
|
2291
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.6B
| $5.43M | ﹤0.01% |
62,051
-9,341
| -13% | -$816K |
2013 Q2
16 quarters
|
|
2292
Crocs
CROX
$5.7B
| $5.42M | ﹤0.01% |
702,515
-3,455,664
| -83% | -$23.2M |
2013 Q2
16 quarters
|
|
2293
Braskem
BAK
$669M
| $5.41M | ﹤0.01% |
261,291
+112,024
| +75% | +$2.31M |
2015 Q3
7 quarters
|
|
2294
Huazhu Hotels Group
HTHT
$13.4B
| $5.41M | ﹤0.01% |
+268,352
| New | +$4.94M |
2017 Q2
0 quarters
|
|
2295
United Natural Foods
UNFI
$2.7B
| $5.39M | ﹤0.01% |
146,889
+55,027
| +60% | +$2.21M |
2015 Q4
6 quarters
|
|
|
MITT
2296
TPG Mortgage Investment Trust
MITT
$182M
| $5.39M | ﹤0.01% |
98,107
+2,882
| +3% | +$161K |
2015 Q4
6 quarters
|
|
|
SGY
2297
DELISTED
Stone Energy
SGY
| $5.38M | ﹤0.01% |
292,571
+9,247
| +3% | +$198K |
2017 Q1
1 quarter
|
|
|
KNL
2298
DELISTED
Knoll, Inc.
KNL
| $5.38M | ﹤0.01% |
268,070
-75,806
| -22% | -$1.7M |
2013 Q2
16 quarters
|
|
2299
CALL
Jacobs Solutions
J
$16.4B
| $5.37M | ﹤0.01% |
+119,325
| New | +$5.31M |
2017 Q2
0 quarters
|
|
|
ARNA
2300
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $5.36M | ﹤0.01% |
317,754
+317,568
| +170,735% | +$4.35M |
2016 Q4
2 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2017 Portfolio in Review
As of Q2 2017, JP Morgan Chase held 5,542 positions worth $438B, down 0.01% from $438B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2017 filing shows 462 new, 1,879 increased, 2,145 reduced and 563 closed positions. Its largest new stake was Altaba Inc: 12,081,650 shares worth $658M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $2.16B.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q2 2017 buy was Altaba Inc: 12,081,650 shares worth $658M.
- JP Morgan Chase added most to iShares Core MSCI EAFE ETF in Q2 2017, an estimated $2.04B increase.
- JP Morgan Chase's biggest Q2 2017 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $2.16B.
- JP Morgan Chase fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $439M.
- JP Morgan Chase's ten largest holdings make up 18% of its $438B portfolio in Q2 2017.
- JP Morgan Chase opened 462 new positions and closed 563 in Q2 2017.
- JP Morgan Chase's portfolio value fell 0.01% quarter-over-quarter to $438B.
Based on JP Morgan Chase's 13F filing for Q2 2017, filed 9 Aug 2017.